Hoshi Iryosanki Co., Ltd. AI Stock Analysis
Want to see JP:7634 full AI Analyst Report?
Hoshi Iryosanki Co., Ltd. (7634) AI Stock Analysis
Hoshi Iryosanki Co., Ltd.
(TSE/TYO:7634)
The overall score reflects a financially sound, low-leverage healthcare company with reliable cash flow and healthy margins as the primary strength, supported by a constructive technical trend and reasonably attractive valuation, while recent margin and earnings softness remain key factors to monitor.
Hoshi Iryosanki Co., Ltd. (7634) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 14.95B
- Dividend Yield
- 1.99%
- Average Volume (3M)
- 615
- Price to Earnings (P/E)
- 10.5
- Beta (1Y)
- 0.10
- Revenue Growth
- 5.25%
- EPS Growth
- -2.63%
- Country
- Japan
- Employees
- 527
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Hoshi Iryosanki Co., Ltd. Business Overview & Revenue Model
Company Description
Hoshi Iryo-Sanki Co., Ltd., a Japanese firm, specializes in the production and distribution of pharmaceutical-grade medical oxygen and nitrous oxide. Its business activities are structured across five distinct divisions: Medical Gas, Home Healthcare,...
How the Company Makes Money
The company primarily makes money by selling and distributing medical devices and healthcare-related products to medical institutions in Japan. Revenue is generated mainly from (1) product sales (i.e., wholesaling/distribution margins earned between...
Hoshi Iryosanki Co., Ltd. Financial Statement Overview
Summary
Revenue and margins are solid and supported by strong cash generation, but recent profit softness, margin compression, and declining return on equity temper the strength.
Income Statement
74PositiveBalance Sheet
88Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.99B | 15.52B | 15.10B | 14.78B | 13.78B | 12.77B |
| Gross Profit | 7.85B | 7.39B | 7.31B | 6.96B | 6.51B | 6.03B |
| EBITDA | 3.08B | 2.87B | 2.81B | 2.86B | 2.71B | 2.48B |
| Net Income | 1.43B | 1.37B | 1.46B | 1.40B | 1.25B | 1.11B |
Balance Sheet | ||||||
| Total Assets | 26.93B | 26.74B | 24.59B | 23.04B | 21.25B | 20.25B |
| Cash, Cash Equivalents and Short-Term Investments | 11.29B | 11.21B | 10.63B | 9.76B | 9.03B | 8.76B |
| Total Debt | 0 | 1.28B | 1.09B | 834.44M | 1.00B | 1.29B |
| Total Liabilities | 6.14B | 6.42B | 5.87B | 5.66B | 5.66B | 5.74B |
| Stockholders Equity | 20.48B | 20.01B | 18.43B | 17.10B | 15.37B | 14.29B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 2.16B | 1.65B | 2.15B | 1.89B | 1.40B |
| Operating Cash Flow | 0 | 2.48B | 2.19B | 2.40B | 2.29B | 1.97B |
| Investing Cash Flow | 0 | -1.54B | -5.28B | -744.85M | -1.06B | -690.26M |
| Financing Cash Flow | 0 | -948.38M | -739.64M | -902.90M | -957.69M | -936.90M |
Hoshi Iryosanki Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7634, the sentiment is Negative. The current price of 4785.00 is below the 20-day moving average (MA) of 4915.25, below the 50-day MA of 5036.64, and below the 200-day MA of 5066.32, indicating a bearish trend. The MACD of -82.51 indicates Positive momentum. The RSI at 31.37 is Neutral, neither overbought nor oversold. The STOCH value of 7.88 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7634.
Hoshi Iryosanki Co., Ltd. Peers Comparison
Overall Rating
JP:763482.1Outperform
JP:667882Outperform
JP:770762.4Neutral
JP:435060Neutral
JP:774354Neutral
JP:760045Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 82Outperform | JPY 14.78B | 10.48 | ― | 1.99% | 5.25% | -2.63% | |
| 82Outperform | JPY 18.47B | 12.39 | ― | 5.95% | 17.11% | 23.02% | |
| 62Neutral | JPY 5.31B | 13.32 | ― | 1.04% | 9.27% | ― | |
| 60Neutral | JPY 15.75B | 17.57 | ― | 2.30% | 6.89% | -55.21% | |
| 54Neutral | JPY 23.79B | 21.83 | ― | 1.91% | 4.13% | -39.39% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | JPY 8.43B | -5.42 | ― | 5.31% | -8.68% | -75.03% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7634 | Hoshi Iryosanki Co., Ltd. | 4785.00 | 102.36 | 2.19% | |
| JP:4350 | Medical System Network Co., Ltd. | 522.00 | 37.09 | 7.65% | |
| JP:6678 | Techno Medica Co., Ltd. | 2167.00 | 284.95 | 15.14% | |
| JP:7600 | Japan Medical Dynamic Marketing, Inc. | 320.00 | -162.41 | -33.67% | |
| JP:7707 | Precision System Science Co.,Ltd | 192.00 | -12.00 | -5.88% | |
| JP:7743 | Seed Co., Ltd. | 786.00 | 231.63 | 41.78% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026
